Chapter 2
Assessing Toxicities in a Clinical
TTrial: Bayesian Inference for
Multivariate Ordinal Data
2.1 Overview
We address modeling and inference for data that include ordinal outcomes nested
within categories. The data format can alternatively be seen as multivariate ordinal
data with each dimension of the multivariate outcome corresponding to one level of a
categorical variable. The motivating application is to model adverse event (toxicity)
data in clinical trials. Toxicity type and severity are usually recorded as categorical
and ordinal outcome, respectively. In a randomized phase III study, in addition to the
efficacy of the study agent, investigators and regulators are also interested in learning
about the toxicity profile of the study agent. Traditionally, simple descriptive statis-
tics such as cross-tabulations have been provided. However, this purely descriptive
approach fails to offer an in-depth understanding of how the treatment affects both
the toxicity type and the severity associated with a specific type of toxicity.
The multinomial probit (MNP) model (Aitchison and Bennett, 1970) and the
More intriguing information
1. A Note on Productivity Change in European Co-operative Banks: The Luenberger Indicator Approach2. The Role of Immigration in Sustaining the Social Security System: A Political Economy Approach
3. Industrial Cores and Peripheries in Brazil
4. The name is absent
5. The name is absent
6. American trade policy towards Sub Saharan Africa –- a meta analysis of AGOA
7. Learning-by-Exporting? Firm-Level Evidence for UK Manufacturing and Services Sectors
8. The Effects of Attendance on Academic Performance: Panel Data Evidence for Introductory Microeconomics
9. Bird’s Eye View to Indonesian Mass Conflict Revisiting the Fact of Self-Organized Criticality
10. Short- and long-term experience in pulmonary vein segmental ostial ablation for paroxysmal atrial fibrillation*